Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MK-2118 |
Trade Name | |
Synonyms | MK2118|MK 2118 |
Drug Descriptions |
MK-2118 is a STING agonist that may activate innate anti-tumor immune response (PMID: 33618600). |
DrugClasses | STING1 Agonist 19 |
CAS Registry Number | NA |
NCIT ID | C176562 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
MK-2118 | MK-2118 | 0 | 1 |
MK-2118 + Pembrolizumab | MK-2118 Pembrolizumab | 0 | 1 |